Dillico is developing an infrastructure of digital tools, equipment and services tailored to your mRNA-LNP production needs, to help you meet the challenges you face. Our proprietary flow-technology solution allows the same piece of equipment to produce mRNA vaccine and therapeutics at any scale, from early development to commercial manufacturing, while offering unique real-time and remote monitoring capabilities, thus facilitating operations and technology transfers.
All-ScaleFlow™– BASED EQUIPMENT
removes major industrial roadblocks in the production of mRNA-LNP making it both unique and competitive
PROCESS INTENSIFICATION
At the core of our solution
Quality
Fully enclosed, monitored and digitalized process
Direct Scale-up & Flexibility
1.000 doses in a few hours to 30 million+ doses per year
Optimized cost
Fully enclosed, monitored and digitalized process
Manufacturing at a regional level
4 sq/m footprint automated equipment with remote control capabilities
